Yoo Ri Na, Kye Bong-Hyeon, Kim HyungJin, Kim Gun, Cho Hyeon-Min
Division of Colorectal Surgery, Department of Surgery, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
Department of Surgery, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Ann Coloproctol. 2023 Feb;39(1):32-40. doi: 10.3393/ac.2021.00696.0099. Epub 2022 Mar 11.
Bowel dysfunction commonly occurs in patients with locally advanced rectal cancer treated with a multimodal approach of chemoradiation therapy (CRT) combined with sphincter-preserving rectal resection. This study investigated the decline in anorectal function using sequential anorectal manometric measurements obtained before and after the multimodal treatment as well as at a 1-year follow-up.
This was a retrospective cohort study conducted in a single center. The study population consisted of patients with locally advanced mid- to low rectal cancer who received the preoperative CRT followed by sphincter-preserving surgery from 2012 to 2016. The anorectal manometric value measured after each treatment modality was compared to demonstrate the degree of decline in anorectal function. A generalized linear model of repeated measures was performed using the manometric values measured pre- and post-CRT, and at 12 months postoperatively.
Overall, 100 patients with 3 consecutive manometric data were included in the final analysis. In the overall cohort study, the mean resting and maximal squeezing pressures showed insignificant decrement post-neoadjuvant CRT. At a 1-year postoperative follow-up, the maximal squeezing pressure significantly decreased. The maximal rectal sensory threshold demonstrated significant reduction consecutively after each following treatment (P<0.001).
The short-term effect of neoadjuvant CRT on the anal sphincters was relatively trivial. The following sphincter-saving surgery resulted in a profound disruption of the anorectal function. Patients with rectal cancer should be consulted on the consequence of multimodal treatment.
肠道功能障碍常见于接受放化疗(CRT)联合保留括约肌的直肠切除术的多模式治疗的局部晚期直肠癌患者。本研究使用多模式治疗前后以及1年随访时获得的连续肛门直肠测压测量值,调查肛门直肠功能的下降情况。
这是一项在单一中心进行的回顾性队列研究。研究人群包括2012年至2016年接受术前CRT并随后进行保留括约肌手术的局部晚期中低位直肠癌患者。比较每种治疗方式后测量的肛门直肠测压值,以证明肛门直肠功能下降的程度。使用CRT前后以及术后12个月测量的测压值进行重复测量的广义线性模型分析。
总体而言,最终分析纳入了100例有连续3次测压数据的患者。在整个队列研究中,新辅助CRT后静息和最大挤压压力的平均值下降不显著。术后1年随访时,最大挤压压力显著降低。每次后续治疗后,最大直肠感觉阈值均连续显著降低(P<0.001)。
新辅助CRT对肛门括约肌的短期影响相对较小。随后的保留括约肌手术导致肛门直肠功能严重受损。应向直肠癌患者咨询多模式治疗的后果。